Latest News
All Times Eastern
- ‘It’s caused a lot of tension in our marriage’: My wife’s family comes visit, hides food and never cleans up. How do we get rid of them?
- Barron's China’s AI Clout Might Be Overstated. What to Know.
- Barron's This Company Makes Costco and Amazon’s Store Brands. Its Stock Is a Buy.
- Barron's This Carbon-Capture Stock Has Big Plans. Why It’s a Buy.
- Barron's Forget Apple and Nvidia. Why June Belongs to Small-Caps.
- Barron's Market Gains as Wall of Worry Crumbles. What Happens Next.
- Judge in FTX bankruptcy rejects media challenge, says customer names can remain secret
- Barron's Commercial Traders Are Net Long Copper. That’s a Good Sign for the Red Metal.
- Mark Zuckerberg says Meta may be ‘primary beneficiary’ of Apple Vision Pro headset
- Biogen stock rallies after full-day halt as FDA panel recommends Alzheimer’s drug for approval
to be replaced
Pfizer Inc.
PFEUS
$
0.03
0.08%
After Hours
$
39.00
After Hours Volume:
474.23K
| Close | Chg | Chg % |
|---|---|---|
| $38.97 | -0.12 | -0.31% |
Volume: 19.78M
65 Day Avg: 24.52M
38.87
Day Range
39.59
36.17
52 Week Range
54.93
Partner Center
Your Watchlists
Recently Viewed Tickers
Overview
PFE Overview
Key Data
- Open $39.28
- Day Range 38.87 - 39.59
- 52 Week Range 36.17 - 54.93
- Market Cap $220.68B
- Shares Outstanding 5.65B
- Public Float 5.64B
- Beta 0.58
- Rev. per Employee $1.120M
- P/E Ratio 7.68
- EPS $5.07
- Yield 4.21%
- Dividend $0.41
- Ex-Dividend Date May 11, 2023
- Short Interest 55.78M 05/31/23
- % of Float Shorted 0.99%
- Average Volume 24.52M
Performance
| 5 Day |
|
| 1 Month |
|
| 3 Month |
|
| YTD |
|
| 1 Year |
|
Analyst Ratings
Number of Ratings 26
Full Ratings
Recent News
3 No-Brainer Stocks to Buy in June
on Motley Fool
The Top Healthcare Stocks to Buy With $100
on Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
on Benzinga.com
2 Unstoppable Stocks to Buy Before the Bull Market
on Motley Fool
Pfizer (PFE) Receives a Hold from SVB Securities
on TipRanks.com
This Is What Whales Are Betting On Pfizer
on Benzinga.com
3 Biotech Stocks to Sell in June Before They Crash and Burn
on InvestorPlace.com
BMO Capital Sticks to Their Buy Rating for Pfizer (PFE)
on TipRanks.com
Could Pfizer Have an Ozempic Killer on the Way?
on Motley Fool
Pfizer Inc.
Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Competitors
| Name | Chg % | Market Cap |
|---|---|---|
| Johnson & Johnson | $416.47B | |
| Eli Lilly & Co. | $423.05B | |
| Abbott Laboratories | $175.25B | |
| Merck & Co. Inc. | $279.93B | |
| Novartis AG | CHF180.14B | |
| AstraZeneca PLC ADR | $228.27B | |
| AstraZeneca PLC | £182.11B | |
| Bristol Myers Squibb Co. | $137.21B | |
| Amgen Inc. | $117.96B | |
| Moderna Inc. | $47.63B |